Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B.
about
NF-kappa B modulation is involved in celastrol induced human multiple myeloma cell apoptosisEvodiamine synergizes with doxorubicin in the treatment of chemoresistant human breast cancer without inhibiting P-glycoproteinMicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cellsA Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB.Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaBCYP19A1 single nucleotide polymorphism associations with CYP19A1, NFκB1, and IL6 gene expression in human normal colon and normal liver samples.The Chinese herb isolate isorhapontigenin induces apoptosis in human cancer cells by down-regulating overexpression of antiapoptotic protein XIAP.Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.Apoptosis in cancer: from pathogenesis to treatment.High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer.miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.Interleukin-1β Affects MDAMB231 Breast Cancer Cell Migration under Hypoxia: Role of HIF-1α and NFκB Transcription Factors.Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of ApoptosisEffects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cellsOrganometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathwayNFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC).From bench to bedside: the growing use of translational research in cancer medicine.Structural studies of NF-κB signaling.Biological determinants of radioresistance and their remediation in pancreatic cancer.Smac mimetic compounds potentiate interleukin-1beta-mediated cell deathThe oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.Knockdown of long non-coding RNA H19 inhibits multiple myeloma cell growth via NF-κB pathway.Anticancer effect of fufang yiliu yin on human hepatocellular carcinoma SMMC-7721 cells.
P2860
Q28538133-4D424ED1-037A-4C40-ADCD-C5305D923A68Q28538867-2B1FFE4F-5D58-452A-AAA6-F43528745111Q33497932-A25DDE8B-94D8-4B31-9624-C98DC2927220Q33515420-E1F0851C-142B-438E-9FA2-72B3AA3B8104Q33775541-5BC160F0-23DE-4B89-97AB-1D4A4FE06BB7Q33943358-715A5A3E-2809-4399-9499-4B84D46C113DQ34294301-1B0B44FD-3942-40E8-8B1C-686617311294Q34891145-FA60E3B1-93F3-4E03-A47B-0ADE4A2A0789Q35097256-C9F41D61-9867-4B4C-9A9E-CA0E25372264Q35397889-17300BB8-926D-4F2D-AD0C-3817BC27EDE1Q35782071-4F6AC51B-0991-46CE-8201-ABAE3345A095Q36140699-7B515121-564E-4569-9AAD-BD058AA86DC0Q36366956-8FBC5586-467F-453F-8741-FD10AE335F27Q36373429-073AB6A1-A6C3-43D7-B6A5-D9328A4504FDQ36485168-068E2D1D-9398-4164-8E09-4D6BFB038E2AQ36952837-3D52948F-39AD-4193-82A1-5DB37E70C5BFQ37488862-11758C0B-CFA8-40C9-9CE4-7393005F7018Q37534990-C9DA0D69-DE07-4FA0-B1BC-5DA455159820Q37698244-EB77E4DB-F7A4-4D23-8AC6-DE37B522A040Q37816940-124A5288-9FB9-4F7C-B889-CA6CA9589913Q39156722-234A2379-2567-43C8-A53A-6686D9742A48Q39642704-8A19D39C-6DB9-438A-ABD6-5671F2332DABQ42278865-86A1344E-8AB1-4FB8-8B5E-F04BE99DD803Q47105619-8150645D-E94B-464C-BBE7-3C639E70059FQ52670957-7F45EED1-522C-4899-B101-9E0434471807
P2860
Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Overcoming cancer therapy resi ...... ns and nuclear factor-kappa B.
@en
Overcoming cancer therapy resi ...... ns and nuclear factor-kappa B.
@nl
type
label
Overcoming cancer therapy resi ...... ns and nuclear factor-kappa B.
@en
Overcoming cancer therapy resi ...... ns and nuclear factor-kappa B.
@nl
prefLabel
Overcoming cancer therapy resi ...... ns and nuclear factor-kappa B.
@en
Overcoming cancer therapy resi ...... ns and nuclear factor-kappa B.
@nl
P2093
P2860
P1476
Overcoming cancer therapy resi ...... ns and nuclear factor-kappa B.
@en
P2093
Theodore S Lawrence
P2860
P407
P577
2009-01-01T00:00:00Z